Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole for Prevention of PONV in Gynecologic Surgery
NCT06488001Phase 2Recruiting
- Sponsor
- Naval Medical Center Portsmouth
- Start
- Aug 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pantoprazole in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Naval Medical Center Portsmouth. Primary endpoint: Postoperative Nausea and Vomiting at 6 weeks. Started Aug 2022; status: recruiting.
02
Drugs
pantoprazole
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06488001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06488001.